"hey boys and girls - don't throw out 2291 just yet"!
Which brings to mind what Margaret Brimble said in a video some years back. Essentially she told the gathering that 'the accountants made us put 2591 in the safe so the company could concentrate resources on 2566 (now called trofinitide).' But she hinted in no uncertain terms that she believed 2591 was going to be the jewel in the crown.
Anyone else pick this up?
Ann: Trofinetide significant clinical benefit in Rett syndrome, page-60
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.40 |
Change
1.130(8.52%) |
Mkt cap ! $1.840B | |||
| Open | High | Low | Value | Volume |
| $13.80 | $14.45 | $13.53 | $15.04M | 1.062M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 871 | $14.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.42 | 3650 | 3 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |